Page last updated: 2024-11-05

thiotepa and Malignant Carcinoid Syndrome

thiotepa has been researched along with Malignant Carcinoid Syndrome in 1 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Malignant Carcinoid Syndrome: A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ley, R1
Vanderhoeft, P1

Other Studies

1 other study available for thiotepa and Malignant Carcinoid Syndrome

ArticleYear
[Bronchial carcinoid. Apropos of 5 cases, one of which was a carcinoid syndrome].
    Acta chirurgica Belgica, 1969, Volume: 68, Issue:4

    Topics: Adenoma; Adult; Aged; Antineoplastic Agents; Bronchial Neoplasms; Carcinoid Tumor; Carcinoma, Adenoi

1969